Stocksigma LogoStocksigma Logo

Lincoln Pharmaceuticals Schedules Board Meeting on 29th Oct'26 for Q2 Results

Lincoln Pharmaceuticals Limited has scheduled a Board of Directors meeting on 29th Oct'26 to consider and approve the standalone and consolidated unaudited

Lincoln Pharmaceuticals Schedules Board Meeting on 29th Oct'26 for Q2 Results

Lincoln Pharmaceuticals Ltd 路 Intimation 路 29 Oct 2026, 5:30 am

Lincoln Pharmaceuticals Schedules Board Meeting on 29th Oct'26 for Q2 Results Lincoln Pharmaceuticals Limited has scheduled a Board of Directors meeting on 29th Oct'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours after the public dissemination of the financial results.

Original exchange filing (PDF)

More announcements from Lincoln Pharmaceuticals Ltd

  • Lincoln Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 29 Oct 2026
  • Un-Audited Financial Results For the Quarter and Half year Ended on September 30 ,2026. 路 29 Oct 2026
  • Un-Audited Financial Results For the Quarter and Half Year ended on September 30, 2026. 路 29 Oct 2026
  • To consider and approve the financial results for the period ended September 30, 2026 路 29 Oct 2026
  • LINCOLN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 29 Oct 2026
  • Change in Senior Management. 路 17 Oct 2026
  • with reference to the above, Please find enclosed herewith the Minutes of 32nd Annual General Meeting of the Company. 路 16 Oct 2026
  • Submission of E-Voting Results of 32nd AGM along with the scrutinizer report as per Regulation 44 of SEBI (LODR) Regulation, 2015. 路 03 Oct 2026

All Lincoln Pharmaceuticals Ltd announcements